-+ 0.00%
-+ 0.00%
-+ 0.00%

MedCap Q3 Adjusted EBITA Rises 30% to SEK 118.3 Million

PUBT·10/23/2026 04:32:18
Listen to the news
MedCap Q3 Adjusted EBITA Rises 30% to SEK 118.3 Million
  • MedCap’s third-quarter 2026 operating profit jumped 78% year over year to SEK 127.1 million.
  • Net sales rose 13% to SEK 566.7 million, driven by acquisitions and organic growth across all business areas.
  • A remeasurement of the XGX Pharma contingent consideration liability boosted quarterly earnings by SEK 36.4 million.
  • Several acquisition processes ended without deals during the quarter, while ongoing discussions remained relatively numerous.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MedCap AB published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.